Hormonal Treatment of In-Situ Breast Carcinoma

A clinical practice guideline for the hormonal treatment of ductal carcinoma in situ. The guideline examines the use of tamoxifen for patients with ductal carcinoma in situ or lobular carcinoma in situ, and provides a recommended treatment plan.